CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Total
Balance at Dec. 31, 2022	$ 30	$ 229	$ 172,471	$ 316,279	$ 15,761	$ 504,770
Increase (decrease) in shareholders' equity
Net Income (Loss) Attributable to the Company				(1,507)		(1,507)
Stock Repurchase		(3)	(5,169)			(5,172)
Vested Restricted Stock and Performance Shares		1	(1,029)			(1,028)
Exercise of Stock Options and Stock Issuance to Directors			308			308
Payment of Equity Issuance Costs			(130)			(130)
Stock-Based Compensation Expense			2,424			2,424
Preferred Stock Dividends Declared for the Period				(3,585)		(3,585)
Common Stock Dividends Declared for the Period				(26,398)		(26,398)
Other Comprehensive Income (Loss)					8,389	8,389
Balance at Sep. 30, 2023	30	227	168,875	284,789	24,150	478,071
Balance at Dec. 31, 2022	30	229	172,471	316,279	15,761	504,770
Balance at Dec. 31, 2023	30	226	168,435	281,944	6,891	457,526
Balance at Jun. 30, 2023	30	227	168,103	291,958	18,249	478,567
Increase (decrease) in shareholders' equity
Net Income (Loss) Attributable to the Company				2,686		2,686
Stock Repurchase			(87)			(87)
Exercise of Stock Options and Stock Issuance to Directors			67			67
Payment of Equity Issuance Costs			(8)			(8)
Stock-Based Compensation Expense			800			800
Preferred Stock Dividends Declared for the Period				(1,195)		(1,195)
Common Stock Dividends Declared for the Period				(8,660)		(8,660)
Other Comprehensive Income (Loss)					5,901	5,901
Balance at Sep. 30, 2023	30	227	168,875	284,789	24,150	478,071
Balance at Dec. 31, 2023	30	226	168,435	281,944	6,891	457,526
Increase (decrease) in shareholders' equity
Net Income (Loss) Attributable to the Company				13,252		13,252
Stock Repurchase			(664)			(664)
Vested Restricted Stock and Performance Shares		1	(1,275)			(1,274)
Issuance of Preferred Stock, Net of Underwriting Discount and Expenses	17		32,979			32,996
Exercise of Stock Options and Stock Issuance to Directors			558			558
Stock Issuance, Net of Equity Issuance Costs		73	132,127			132,200
Stock-Based Compensation Expense			2,307			2,307
Preferred Stock Dividends Declared for the Period				(4,936)		(4,936)
Common Stock Dividends Declared for the Period				(28,887)		(28,887)
Other Comprehensive Income (Loss)					(7,296)	(7,296)
Balance at Sep. 30, 2024	47	300	334,467	261,373	(405)	595,782
Balance at Jun. 30, 2024	47	231	207,882	268,269	15,386	491,815
Increase (decrease) in shareholders' equity
Net Income (Loss) Attributable to the Company				6,227		6,227
Exercise of Stock Options and Stock Issuance to Directors			89			89
Stock Issuance, Net of Equity Issuance Costs		69	125,835			125,904
Stock-Based Compensation Expense			661			661
Preferred Stock Dividends Declared for the Period				(1,878)		(1,878)
Common Stock Dividends Declared for the Period				(11,245)		(11,245)
Other Comprehensive Income (Loss)					(15,791)	(15,791)
Balance at Sep. 30, 2024	$ 47	$ 300	$ 334,467	$ 261,373	$ (405)	$ 595,782